Nephrology Doctors in Bayamon, PR Accepting Medicare

6 Nephrology doctors found. Showing 1 - 6

Dr. Ana I Rivera De La Vega, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 100 Paseo San Pablo, Edif. Dr. Arturo Cadilla, Suite 201, Bayamon, PR 00961 Phone: 787-778-8774    Fax: 787-269-6190

Dr. Jose Campos, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: Hgwy#2 Km11.7, Bayamon Medical Plaza 406, Bayamon, PR 00959 Phone: 787-785-8770    Fax: 787-787-0908

Rafael E Rosario Amador, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: Pro-health Clinical Services, Bayamon Health Center 2nd Floor, Calle Manuel Rossi, Bayamon, PR 00961 Phone: 787-269-6590

Alcides Gil Escudero, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 68 Santa Cruz Avenue, Torre San Pablo Suite 701, Bayamon, PR 00959 Phone: 787-798-4527    Fax: 787-790-4580

Mr. Edwin A Mora-ruiz, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 66 Calle Santa Cruz, Suite 503, Bayamon, PR 00961 Phone: 787-740-1011    Fax: 787-740-1008

Samuel Padilla Machuca, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1845 Bayamon Medical Plaza, Ste 509, Bayamon, PR 00960 Phone: 787-786-9200    Fax: 787-786-9700

News Archive

Studies confirm benefit of plasma genotyping to predict treatment outcomes for NSCLC patients

The benefit of plasma genotyping to predict treatment benefit in patients with non-small-cell lung cancer (NSCLC) is confirmed in three studies presented today at the European Lung Cancer Conference (ELCC) 2016 in Geneva, Switzerland. Researchers however warned that plasma tests are unlikely to fully replace tissue biopsies.

Researchers use SNAP technology to assess fetal gene expression in amniotic fluid

Researchers have demonstrated the feasibility of focused fetal gene expression analysis of target genes found in amniotic fluid using Standardized NanoArray PCR (SNAP) technology.

FDA issues 510(k) clearance to Simplexa Influenza A H1N1 (2009) test on 3M Integrated Cycler

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.

Study to examine how breastfeeding impacts cost of healthcare for very low birth weight babies

The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants – babies less than 1500 grams.

Homeless Brisbane population at risk of dying early: survey

A recent survey has shown that more than 50 percent of Brisbane's homeless community is at a higher risk of early deaths. The survey was conducted by interviewing at least 231 people who live on Brisbane's streets, using an index to determine their risk of dying or mortality risk.

Read more Medical News

› Verified 8 days ago